Newsbenzinga
What's Going On With Capricor Therapeutics Stock On Friday?
· Published
Article summary
Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its Duchenne muscular dystrophy therapy.
An excerpt from the original article.
Comments —
Loading comments…